The University of Texas MD Anderson Cancer Center
Pediatric Hematology-Oncology fellowship · Houston, TX · Program website
Fellows here publish most often with Rodrigo E. Mejia, Ali Ahmad, and Clark Andersen at The University of Texas MD Anderson Cancer Center. How fellows publish ↓
- 10
- Fellows
- 20%
- Have published here
- 0.16
- Papers per fellow-year
- 0%
- Papers led by a fellow
- 100%
- With a co-author at The University of Texas MD Anderson Cancer Center
Roster from the program's own page mdanderson.org, collected 2026-11-07: 10 current fellows in 3 classes. Something off? Tell us
Papers
By this program's leadership and fellows since 2022, 46 in all · 2 with a fellow author. Updated 2026-11-08.
- Revumenib in Pediatric Acute Leukemia: Clinical Activity and Differentiation Syndrome from the AUGMENT-101 StudyBranko Cuglievan et al. · Clinical Lymphoma Myeloma & Leukemia · 2026
- 1753: POSTOPERATIVE CARE OF PEDIATRIC ONCOLOGIC MICROVASCULAR FLAP SURGERYAli Ahmad et al. · Critical Care Medicine · 2026
Trainees aren't named, for privacy. A paper is included when one of its authors is a current resident or fellow, or a graduate of the last two years, and it came out during their training.
How fellows publishauthor positions, co-authorship, ranks
Papers by current residents and fellows, and alumni within two years, published during training. Based on 3 of 10 trainees matched to publication records. Trainees with no match count as not yet published, so these figures are a floor.
Faculty detailsh-index, papers and author positions per person
Program leadership from the program's own pages, matched to publications. Leadership is mostly clinician-educators, so these numbers describe the teaching team, not the department's research. Works since 2022-01-01.
| Name | Research topics | h (lifetime) | Works | 1st | Last | Median FWCI |
|---|---|---|---|---|---|---|
| Priti Tewari, M.D.PD | Acute Lymphoblastic Leukemia research; CAR-T cell therapy research | 16 | 45 | 0 | 2 | 0.59 |
10 trainees are counted above but never listed by name.
Pediatric Hematology-Oncology at The University of Texas MD Anderson Cancer Centershared by every program there, not this program's own
Institution-level: all pediatric hematology-oncology publications from The University of Texas MD Anderson Cancer Center and affiliated institutions, since 2022. Updated 2026-11-08; refreshed daily.
Works per year · * 2026 so far
Pediatric Hematology-Oncology research topics at The University of Texas MD Anderson Cancer Center
Papers in the window; each links to the list on OpenAlex.
Most cited at The University of Texas MD Anderson Cancer Center since 2024
All pediatric hematology-oncology papers there on OpenAlex
- The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023Lisa M Force et al. · The Lancet · 2025 · PubMed · cited 515
- Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumoursAshley M. Holder et al. · Nature reviews. Cancer · 2024 · PubMed · cited 319
- [177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 studySimron Singh et al. · The Lancet · 2024 · PubMed · cited 441
- Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in OncologyAl B. Benson et al. · Journal of the National Comprehensive Cancer Network · 2024 · PubMed · cited 417
- Management of Fatigue in Adult Survivors of Cancer: ASCO–Society for Integrative Oncology Guideline UpdateJulienne E. Bower et al. · Journal of Clinical Oncology · 2024 · PubMed · cited 328
- Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trialSandra P. D’Angelo et al. · The Lancet · 2024 · PubMed · cited 328
- Ribociclib plus Endocrine Therapy in Early Breast CancerDennis J. Slamon et al. · New England Journal of Medicine · 2024 · PubMed · cited 440
- Embracing cancer complexity: Hallmarks of systemic diseaseCharles Swanton et al. · Cell · 2024 · PubMed · cited 570
- Unveiling the mechanisms and challenges of cancer drug resistanceSameer Ullah Khan et al. · Cell Communication and Signaling · 2024 · PubMed · cited 444
- Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trialDavid Marín et al. · Nature Medicine · 2024 · PubMed · cited 560
Add to your program's websitea badge, your paper list, a feed
For program directors and coordinators. Both update with the site and need no account.
<a href="https://openprograms.org/programs/university-texas-md-anderson-cancer-center-peds-heme-onc"><img src="https://openprograms.org/programs/university-texas-md-anderson-cancer-center-peds-heme-onc/badge.svg" alt="The University of Texas MD Anderson Cancer Center Pediatric Hematology-Oncology fellowship on OpenPrograms" height="20"></a><iframe src="https://openprograms.org/embed/university-texas-md-anderson-cancer-center-peds-heme-onc" title="Recent papers, The University of Texas MD Anderson Cancer Center Pediatric Hematology-Oncology fellowship" width="100%" height="520" style="border:0" loading="lazy"></iframe>Something wrong or missing on this page? Use the correction form below; changes show up in both.